Exclusive: AbbVie nears roughly $8 billion deal for drug developer...

added job (Closing Date: )

2023-12-08 05:38:40 -

Exclusive: AbbVie nears roughly $8 billion deal for drug developer Cerevel-sources

Location

Type

Status

Open

AbbVie Inc is nearing an approximately $8 billion deal to acquire Cerevel Therapeutics Holdings Inc , a developer of drugs for neurological conditions such ...

0 Comments 0 Shares 0 Reviews